p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy

Surgical Oncology

Volumn 15, Issue 4, 2006, Pages 211-216

  Lin, Li Ching ^a   Lee, Hao Hsien ^a   Hwang, Wei Shou ^a   Li, Chien Feng ^a   Huang, Chien Tai ^a   Que, Jenny ^a   Lin, Kuei Li ^a   Lin, Forn Chia ^a   Lu, Chin Li ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

Neoadjuvant therapy; p27; p53; Rectal cancer

Indexed keywords

PROTEIN BCL 2; PROTEIN P27; PROTEIN P53;

ADJUVANT THERAPY; ADULT; AGED; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; STATISTICAL SIGNIFICANCE; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; GENES, P53; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34248662655     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suronc.2007.01.001     Document Type: Review

References (29)

1. Camma C., Giunta M., Fiorica F., et al. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. Journal of the American Medical Association 284 8 (2000) 1008-1015
2. Wouters B.G., Denko N.C., Giaccia A.J., et al. A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy. Oncogene 18 47 (1999) 6540-6545
3. Chang B.D., Xuan Y., Broude E.V., et al. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18 34 (1999) 4808-4818
4. Bunz F., Hwang P.M., Torrance C., et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. Journal of Clinical Investigation 104 3 (1999) 263-269
5. Bukholm I.K., and Nesland J.M. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Archiv 436 3 (2000) 224-228
6. Xu S.Q., and El-Deiry W.S. p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochemical and Biophysical Research Communications 269 1 (2000) 179-190
7. Tian H., Wittmack E.K., and Jorgensen T.J. p21WAF1/CIP1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Research 60 3 (2000) 679-684
8. Gongoll S., Peters G., Mengel M., Piso P., Klempnauer J., Kreipe H., et al. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology 123 (2002) 1478-1484
9. Kouraklis G., Kakisis J., Theoharis S., Tzonou A., Glinavou A., Raftopoulos J., et al. Prognostic significance and correlation with survival of bcl-2 and TGF-beta RII in colon cancer. Digestive Diseases and Sciences 48 (2003) 2284-2289
10. Rider W.D., Palmer J.A., Mahoney L.J., et al. Pre-operative irradiation in operable cancer of the rectum: report of Toronto trial. Canadian Journal of Surgery 20 (1997) 335-338
11. Koder I.J., Shemesh E.I., Fry R.D., et al. Preoperative irradiation for rectal cancer: improved local control and long-term survival. Annals of Surgery 209 (1989) 606-614
12. Gerard A., Buyser M., Nordlinger B., et al. Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Annals of Surgery 208 (1988) 606-614
13. Stockholm Rectal Cancer Study Group. Preoperative radiotherapy for locally advanced rectal carcinoma: results of a prospective randomized trial. Diseases of the Colon and Rectum 37 (1994) 1205-1214
14. Medical Research Council Rectal Cancer Working Party. Randomized trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348 (1996) 1605-1610
15. Swedish Rectal Cancer Trial. Improved survival with pre-operative radiotherapy in respectable rectal cancer. New England Journal of Medicine 336 (1997) 980-987
16. Krook J.E., Moertel C.G., Gunderson L.L., et al. Effective surgical adjuvant therapy for high risk rectal carcinoma. New England Journal of Medicine 324 (1991) 709-715
17. O'Connell M.J., Martenson J.A., Wieand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. New England Journal of Medicine 331 (1994) 502-507
18. Ahmad N.R., and Nagle D. Long-term results of pre-operative radiation therapy alone for stage T3 and T4 rectal cancer. British Journal of Surgery 1997 (1997) 1445-1448
19. Grann A., Minsky B.D., Cohen A.M., et al. Preliminary results of preoperative 5-fluorouracil low-dose leucovorin, and concurrent radiation therapy for clinically respectable T3 rectal cancer. Diseases of the Colon and Rectum 40 (1997) 515-522
20. Burke S.J., Percarpio B.A., Knight D.C., et al. Combined pre-operative radiation and mitomycin/5-fluorouracil treatment for locally advanced rectal adenocarcinoma. Journal of the American College of Surgeons 187 (1998) 164-170
21. kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Annals of Surgical Oncology 8 4 (2001) 311-318
22. Lewin B. Oncogene and cancer. Genes (1997), Oxford University Press, New York, USA p. 1131-73
23. Lewin B. Oncogene and cancer. Genes (1997), Oxford University Press, New York, USA p. 1122-6
24. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after pre-operative radiochemotherapy. International Journal of Colorectal Disease 12 (1997) 19-23
25. Hammarberg C., Tribukait B., and Ohman U. Early effects of pre-operation upon irradiation upon the cell cycle composition in rectal adenocarcinomas. Acta Radiologica Oncology 25 (1986) 45-50
26. Moore H.G., Shia J., Klimstra D.S., et al. Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome. Annals of Surgical Oncology 11 11 (2004) 955-961
27. Waldman S.A. Markers of cell cycle-mediated drug resistance and prognosis of patients receiving preoperative combined modality therapy for rectal cancer. Annals of Surgical Oncology 11 11 (2004) 945-950
28. Roublevskaia I.N., Polevoda B.V., Ludlow J.W., et al. Induced 2/M arrest and apoptosis in human epidermoid carcinoma cell line by semisynthetic drug Ukrain. Anticancer Research 20 5A (2000) 3163-3167
29. Hall EJ. Radiobiology for the radiologist. In: Radiosensitivity and cell age in mitotic cycle, 4th ed. USA: J.B. Lippincott Company; 1994. p. 91-107.